Partner. Practice focuses on commercial litigation, with an emphasis on intellectual property disputes. Expertise advising clients regarding the licensing of intellectual property and technology, and pharmaceutical clients regarding pricing regulation issues, including those relating to the Patented Medicines Prices Review Board (“PMPRB”).
Has been counsel on a number of significant cases involving patent validity and infringement, and has acted on the leading cases involving the assessment and quantification of damages, both for patent infringement and pursuant to section 8 of the Patented Medicines (NOC) Regulations. Appears regularly before the Federal Court and Federal Court of Appeal.